Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. (symbol: MIR) is a leading provider of radiation detection, measurement, analysis, and monitoring products and services. Mirion serves a diverse range of markets including nuclear power, medical, military, and homeland security, ensuring the safety of people, property, and the environment from nuclear and radiological hazards for over 50 years.
Headquartered in the San Francisco Bay Area, Mirion operates facilities across Europe, Asia, and North America, making it a globally recognized entity in the realm of radiation safety solutions. The company is structured into two main segments:
- Medical Segment: This segment focuses on radiation oncology quality assurance, providing critical patient safety solutions in diagnostic imaging and radiation therapy centers. Mirion’s advanced technologies ensure precise and reliable results, significantly enhancing patient care and safety.
- Technologies Segment: Catering to nuclear energy, defense, laboratories, scientific research, and other industrial markets, this segment represents the largest portion of the company’s revenue. Mirion's products and services in this segment are vital for accurate measurement and analysis in high-stakes environments, contributing to scientific advancements and industrial safety.
Mirion Technologies’ recent achievements include the development of cutting-edge radiation detection tools and strategic partnerships aimed at enhancing global safety standards. The company’s commitment to innovation is underscored by its continuous investment in R&D, resulting in reliable and advanced products that meet the evolving needs of its diverse clientele.
Financially, Mirion Technologies has demonstrated solid performance, with a robust revenue stream primarily driven by the Technologies segment. The company’s global presence, coupled with its specialized expertise, positions it as a critical player in the fields it serves.
Mirion Technologies, Inc. (NYSE: MIR) announced the release of the SunSCAN™ 3D cylindrical water scanning system by its subsidiary Sun Nuclear Corporation.
The system improves radiation therapy workflows, offering hyper-accurate dosimetry with a precision of 0.1 mm for stereotactic treatments. It features faster setup times and new SunDOSE™ software for enhanced quality assurance.
Demonstrations will take place at the ESTRO 2022 conference from May 6-10 in Copenhagen, with an online release event on May 17.
Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Goldman Sachs Industrials and Materials Conference on May 10, 2022, at 11:20 AM ET in New York, NY. The presentation will be available for live streaming on their website, with an archived version accessible for two weeks after the event. Mirion Technologies specializes in detection and monitoring solutions across various sectors, including nuclear and defense, and operates in 13 countries.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Wells Fargo’s 2022 Industrials Conference on Thursday, May 5, 2022, at 12:00 PM ET in New York, NY.
The presentation will be webcast live and accessible at Mirion's website, where it will be archived for two weeks following the event. Mirion provides detection, measurement, analysis, and monitoring solutions across various sectors, employing around 2,600 people globally.
Mirion Technologies (NYSE: MIR) will release its financial results for the first quarter of 2022 on May 4, 2022, followed by a conference call at 11:00 am ET. Participants can join by calling 1-844-826-3033 or 1-412-317-5185. A live webcast will also be available at Mirion's Investor page. A telephonic replay will be accessible until May 18, 2022. Mirion is a leader in detection, measurement, and analysis solutions for various markets, including nuclear and medical, employing around 2,600 people across 13 countries.
Mirion Technologies (NYSE: MIR) has announced an upgraded Cloud-hosted, SaaS option for its SunCHECK™ Quality Management Platform. This platform enhances workflows for Radiation Therapy Quality Assurance, improving patient safety and reducing operational burdens. The SaaS model offers better scalability and reliability, utilizing Amazon Web Services for infrastructure. Over 1,600 users currently utilize SunCHECK software, showcasing its significance in cancer care. The SaaS solution is designed to meet diverse clinic needs and will be demonstrated at ESTRO 2022 in Copenhagen.
Mirion Technologies reported a 18% increase in revenue for Q4 2021, totaling $177.8 million, compared to $150.8 million in Q4 2020. The company posted a GAAP net loss of $23.0 million for the same period. Adjusted EBITDA rose to $44.5 million, up from $31.2 million in the previous quarter. For the fiscal year 2022, Mirion forecasts adjusted revenue growth between 5.5% and 7.5% and adjusted EBITDA of $175 million to $185 million. The company is facing supply chain challenges but remains confident in its growth prospects.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Citi Global Industrial Tech and Mobility Conference in Miami, FL, on February 24, 2022, at 1:50 PM ET. The presentation will be webcast live, with an archived version available afterward. Mirion is a premier provider of detection and monitoring solutions for nuclear, defense, and medical sectors and operates in 13 countries, employing around 2,600 people. For additional details, visit Mirion.com.
Mirion Technologies, Inc. (NYSE: MIR) will release its financial results for the fourth quarter and fiscal year ended
Kaman Composites – Vermont, a subsidiary of Kaman Corporation (NYSE:KAMN), has partnered with Mirion Technologies (NYSE:MIR) to expand its medical imaging program. This collaboration involves Kaman supplying surgical C-Arm tabletops, with the first deliveries scheduled for Q2 2022. Kaman Composites possesses 40 years of expertise in designing composite components and is recognized for its rigorous manufacturing standards. This partnership signifies Kaman's growing presence in the medical technology sector while maintaining its aerospace industry role.
Sun Nuclear Corporation, a subsidiary of Mirion Technologies (NYSE: MIR), has announced the full program for the 2022 QA & Dosimetry Symposium (QADS), scheduled for April 8-9 in Orlando, Florida. The event will focus on Quality and Patient Safety in Radiation Oncology, featuring six session themes and over 20 presentations. Topics include Cybersecurity in Healthcare and Practical Dosimetry. Notably, the symposium will address challenges posed by cyberattacks and the COVID-19 pandemic. Registration is open until January 21, 2022.
FAQ
What is the current stock price of Mirion Technologies (MIR)?
What is the market cap of Mirion Technologies (MIR)?
What does Mirion Technologies do?
Where is Mirion Technologies headquartered?
What are the main segments of Mirion Technologies?
What markets does the Technologies segment serve?
Which segment generates the most revenue for Mirion Technologies?
How long has Mirion Technologies been in operation?
In which regions does Mirion Technologies have facilities?
What is the focus of the Medical segment?
What recent achievements has Mirion Technologies made?
How does Mirion Technologies contribute to scientific research?
